China Universal Asset Management Co. Ltd. - China Universal SSE STAR Brand Name Drug ETF (SHA:589120)
0.8530
+0.0010 (0.12%)
At close: Sep 22, 2026
SHA:589120 Holdings Information
SHA:589120 is an equity ETF with a total of 34 individual holdings. The top holdings are Shanghai Allist Pharmaceuticals stock at 9.84%, BeOne Medicines AG at 9.74%, Sichuan Biokin Pharmaceutical at 8.07%, RemeGen at 7.75%, and Suzhou Zelgen Biopharmaceuticals at 7.26%.
Total Holdings
34
Top 10 Percentage
64.34%
Asset Class
Equity
ETF Category
Health Care
Assets
n/a
PE Ratio
36.89
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | SHA: 688578 | Shanghai Allist Pharmaceuticals Co., Ltd. | 9.84% |
| 2 | SHA: 688235 | BeOne Medicines AG | 9.74% |
| 3 | SHA: 688506 | Sichuan Biokin Pharmaceutical Co.,Ltd. | 8.07% |
| 4 | SHA: 688331 | RemeGen Co., Ltd. | 7.75% |
| 5 | SHA: 688266 | Suzhou Zelgen Biopharmaceuticals Co., Ltd. | 7.26% |
| 6 | SHA: 688180 | Shanghai Junshi Biosciences Co., Ltd. | 6.10% |
| 7 | SHA: 688131 | Shanghai Haoyuan Chemexpress Co., Ltd. | 4.73% |
| 8 | SHA: 688319 | Chengdu Olymvax Biopharmaceuticals Inc. | 4.21% |
| 9 | SHA: 688166 | BrightGene Bio-Medical Technology Co., Ltd. | 3.59% |
| 10 | SHA: 688336 | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd | 3.04% |
| 11 | SHA: 688278 | Xiamen Amoytop Biotech Co., Ltd. | 2.99% |
| 12 | SHA: 688382 | InventisBio Co., Limited | 2.80% |
| 13 | SHA: 688321 | Shenzhen Chipscreen Biosciences Co., Ltd. | 2.75% |
| 14 | SHA: 688222 | HitGen Inc. | 2.60% |
| 15 | SHA: 688428 | InnoCare Pharma Limited | 2.57% |
| 16 | SHA: 688192 | Dizal (Jiangsu) Pharmaceutical Co., Ltd. | 2.50% |
| 17 | SHA: 688062 | Mabwell (Shanghai) Bioscience Co., Ltd. | 2.28% |
| 18 | SHA: 688202 | Shanghai Medicilon Inc. | 2.18% |
| 19 | SHA: 688520 | Sinocelltech Group Limited | 1.62% |
| 20 | SHA: 688710 | Shanghai InnoStar Bio-tech Co., Ltd. | 1.60% |
| 21 | SHA: 688758 | Suzhou Sepax Technologies Co., Ltd. | 1.54% |
| 22 | n/a | Cash | 1.45% |
| 23 | SHA: 688621 | Beijing Sun-Novo Pharmaceutical Research Co., Ltd. | 1.44% |
| 24 | SHA: 688185 | CanSino Biologics Inc. | 1.37% |
| 25 | SHA: 688513 | Chengdu Easton Biopharmaceuticals Co., Ltd. | 1.30% |
As of Jun 30, 2026